Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › LRRK2 inhibitors for the treatment of Parkinson's disease

LRRK2 inhibitors for the treatment of Parkinson's disease

US Patent 10618901 · Granted Apr 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biphenyl fluorine double bond derivative, preparation method therefor, and pharm2025
Compounds active towards nuclear receptors2025
Infant formula milk powder rich in milk fat globule membrane protein, phospholip2025
Thienopyridinone compounds2025
Next-generation modulators of stimulator of interferon genes (STING)2025
Using nucleosome interacting protein domains to enhance targeted genome modifica2025
Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof2025
Method for manufacturing memory device and memory2024
TEAD inhibitors and methods of uses thereof2024
Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof2024
Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof2024
Using nucleosome interacting protein domains to enhance targeted genome modifica2024